Two of the largest genome-wide association studies to date identified three genes – clusterin (also known as apolipoprotein J), phosphatidylinositol-binding clathrin assembly protein (PICALM) and complement receptor 1 (CR1) – that each contribute a small amount to the total AD risk [30, 31]. This evidence concerns the gene PICALM and Alzheimer disease.